Currently, treatment for rheumatoid arthritis and other inflammatory arthropathies is often ineffective in ameliorating the progression of the disease, particularly the invasive destruction of cartilage and bone by rheumatoid synovium. Multiple aspects of this inflammatory process are mediated by the synovial lining cells (synoviocytes). Genetic modification of these cells in vivo represents a potential method for the treatment of these conditions. In this report, we describe a novel technique for the genetic transduction of synovial lining cells in vivo using recombinant adenoviral vectors and intraarticular injection techniques. Purified high titer suspensions of a recombinant adenoviral vector containing the gene for Escherichia coli beta-galactosidase (AdCMVlacZ) were directly injected into the hind knees of New Zealand white rabbits. Synovial tissues were then examined for transgenic lacZ expression using a combination of in situ staining for beta-galactosidase activity, immunohistochemical staining, and transmission electron microscopy. High efficiency gene transfer and lacZ expression was observed in both type A and type B synoviocytes throughout the articular and periarticular synovium of the rabbit knee, with continued expression of transgenic lacZ detected for > or = 8 wk after infection. 
Introduction
Among acquired autoimmune conditions are the inflammatory arthropathies, a heterogeneous group of diseases that in the case ofrheumatoid arthritis alone affects . 1% ofthe population (1) . In general, these diseases are characterized by abnormal proliferation ofthe specialized epithelial cells known as synoviocytes that form the lining tissue of the intraarticular space of diarthrodial joints (2) . Based on morphological and functional criteria, synoviocytes have been characterized as type A (also referred to as type I) or type B (also referred to as type II) cells (3, 4) . Type A synoviocytes are presumably de- rived from macrophage/monocyte precursors, exhibit phago-cytic activity, and may function as antigen presenting cells. Type B cells are more fibroblast-like in appearance and are associated with the production of hyaluronic acid and other components ofjoint fluid (5) .
Alterations in the normal biology of the synoviocytes are important in the development and maintenance of the pathologic process associated with rheumatoid arthritis, including invasion and destruction ofarticular cartilage and bone (6) (7) (8) .
In addition to the production ofelastase and collagenase, synoviocytes mediate this pathophysiologic process by producing and upregulating the expression of cell surface proteins important in the recruitment and activation oflymphocytes and macrophages within rheumatoid synovium (9) (10) (11) (12) .
The directed overexpression of biologically active antiinflammatory proteins by synoviocytes would be a potential therapeutic intervention designed to prevent the inflammatory cascade and the development ofthe transformed synoviocyte phenotype associated with rheumatoid arthritis (2, 6) . Somatic cell gene transfer to synoviocytes in vivo would be one method to accomplish this goal. Synoviocytes are easily accessed via the intraarticular space, are relatively long lived, and thus represent an ideal target for gene transfer vectors. Because synoviocytes normally have a low rate ofcell turnover in vivo, they are more suitable for genetic transduction with recombinant adenoviruses rather than retroviruses (vectors that require cell division for proviral integration and transgene expression). The feasibility of using recombinant adenoviruses for direct gene transfer to synoviocytes in vivo is addressed in this report, where we describe long term expression oflacZ by rabbit synoviocytes after intraarticular infection with a recombinant adenoviral vector containing the gene for Escherichia coli f3-galactosidase.
Methods
Recombinant adenoviral vectors. Replication defective adenoviral vectors are deleted of sequences spanning EIA, EIB, and a portion of the E3 region, impairing the ability of this virus to replicate or transform nonpermissive cells ( 13) . In the vector AdCMVlacZ, the early enhancer/promoter of the cytomegalovirus (CMV)' was used to drive transcription of lacZ with an SV40 polyadenylation sequence cloned downstream from this reporter. A more detailed description of this virus is provided elsewhere. We used an identically derived Ad5 adenoviral vector, AdCSV, as a control. AdCSV does not contain the gene for Animals and intraarticular injections. All animal protocols were approved by the University Committee on the Use and Care of Animals and performed according to institutional guidelines. Male New Zealand white rabbits 2 kg in weight were used for these experiments. Before the procedure, rabbits were anesthetized with a single intramuscular dose of ketamine/xylazine (25 mg/kg ketamine and 5 mg/kg xylazine), and the area surrounding both hind knees was shaved and prepared with providone/iodine. Using sterile technique and a medial approach, 1 ml of purified AdCMVIacZ suspended in PBS was infused into the intraarticular space of the right knee over a period of 30 s. The left knee was either left uninjected (n = 3 rabbits) or was prepared in an identical manner and injected with the control vector AdCSV (n = 4 rabbits).
In situ stainingfor f3-galactosidase transgene expression. At 1 -8-wk intervals after infection, animals were euthanized with an intravenous overdose of pentobarbital. Both hind knees were infused with 10 ml of 2% paraformaldehyde in Pipes pH 6.9. Knee joints were removed en bloc, the intraarticular space was exposed by sharp dissection, and samples immersed in the same fixative for one additional hour at 40C. Samples were washed twice in PBS/ 2 mM MgCI2, and reacted in 5 mM K3Fe(CN)6, 2 mM MgCl2, 0.01% sodium deoxycholate, 0.02% NP-40, and 1 mg/ml 5-bromo-4-chloro-3-indolyl-3-D-galactoside (X-gal) in PBS for 30 min at 37°C (15). The intraarticular spaces were then widely exposed by dissection, inspected visually and photographed en fosse using a stereoscopic dissecting microscope (Nikon).
Histology and transmission electron microscopy. Tissues stained with X-gal were processed for routine histology or electron microscopy by postfixing in 2% glutaraldehyde/PBS. Samples containing bone were decalcified by treatment with 25% formic acid/7.5% sodium citrate, neutralized in 5% sodium sulfate, and further fixed in 2% glutaraldehyde/PBS. Samples were embedded in glycomethacrylate, and 5-Am sections were cut using a microtome, mounted onto glass slides, and counterstained with hematoxylin/eosin. Samples for electron microscopy were postfixed in 2% glutaraldehyde, 1.5% paraformaldehyde, and 0.0015% CaCl2 in 0.1 M Na cacodylate, followed by 1% osmium tetroxide in 0.1M Na cacodylate containing 5% sucrose. Samples were then dehydrated in ethanol and embedded in Spurr's medium using previously described methods ( 16) . Articularandperiarticular tissues from control knees were processed identically for both light and electron microscopy.
Immunohistochemistry. Samples for immunohistochemical staining were prepared by isolation of the synovial membrane by sharp dissection and fresh freezing in OCT (Miles Inc., Elkhart, IN). Sections (6 Mm) were prepared on a Bright cryostat and placed onto poly-L-lysine coated slides. Slides were postfixed in methanol at -20°C and blocked by incubation in 1% BSA/ PBS for 1 h at 20°C. Slides were then incubated for 1 h with biotin conjugated to monoclonal (mouse) anti-#-galactosidase (Sigma), rinsed three times in PBS, and reacted with avidin-AMCA (Vector Labs, Burlingame, CA) for 1 h at 20°C. Sections of infected synovium were also reacted with antibodies to adenoviral structural proteins. Incubations were performed for 1 h at room temperature with FITC-conjugated goat antihexon (Biodesign International, Kennebunkport, ME) or monoclonal (murine) antiadenoviral coat protein (BioGenex Laboratories, San Ramon, CA), followed by incubation with FITC-conjugated goat anti-murine IgG (Vector Labs). After rinsing in PBS, slides were examined and photographed using fluorescent microscopy after excitation with light at 350 nm (AMCA) or 492 nm (FITC). Light field photomicrographs were routinely taken of the same fields using Nomarski optics.
Detection ofhumoral immune response against adenoviralproteins and E. coli f3-galactosidase. Serum 
Results
In situ staining for f-galactosidase transgene expression. Visual examination ofthe intraarticular surfaces ofknees injected with the vector AdCMVlacZ showed extensive expression of f-galactosidase throughout the synovial tissues at 1 wk (Fig. 1  A) and < 8 wk (Fig. 1 B) after the administration of AdCMVlacZ. Contralateral control joints that were uninfected or infected with an Ad5 vector that did not contain the gene for f.-galactosidase showed no evidence of blue staining cells at 1 wk (Fig. 1 G) or throughout the experimental period. Qualitatively, the number oflacZ expressing cells throughout the synovium progressively declined from I to 8 wk after infection. The number of synoviocytes expressing lacZ activity at 8 wk was estimated to be 25% of that observed at 1 wk after injection. Histology and electron microscopy. Synovial lining cells form a serosal surface that covers multiple types ofsubsynovial tissue (3) (4) (5) . Routine histologic examination of articular and periarticular tissues obtained 1 wk after infection with AdCMVlacZ showed X-gal staining cells present within vascular synovial villi, as well as in the synovial tissue covering tendons, bone, articular cartilage, and subsynovial adipose tissue (Fig. 1, C-F (Fig.  3 B) . Additionally, the ultrastructural appearance ofboth type A and type B synoviocytes was normal in rabbits infected with AdCMVlacZ or AdCSV and no intranuclear inclusion bodies were observed.
Western blot analysis. A potential concern with the use of adenoviral vectors is the development of a humoral immune response by the host animal. To address this possibility, experiments were performed on sera obtained from the entire experimental cohort (n = 7 animals) before and after intraarticular infection with adenoviral vectors. Sera were analyzed by Western blot for the development of antibodies to structural proteins of AdCMVlacZ, as well as to E. coli j3-galactosidase (Fig.   4 ). Low titers of antibodies reactive against several adenoviral structural proteins of Ad5 serotype vector AdBglII were present in the preimmune sera obtained from all ofthe experimental animals. (The presence ofthese antibodies were determined after prolonged exposures ofthe micrographs.) Increases in the titer of preexisting antibodies, as well as the development of novel antibodies directed against additional adenoviral structural proteins, occurred over the time course ofthe experiment. Sera from the infected animals consistently cross-reacted with hexon, penton base, hexon associated, and vertex region proteins ( 18 Fig. 4 A. In addition, antibodies directed against E. coli f(-galactosidase were observed in one animal (Fig. 4 B) in both pre-and postimmune sera.
Discussion
Previously, recombinant adenoviruses have been demonstrated to mediate expression of foreign transgenes in vivo in a variety of terminally differentiated cell types including neurons, glia, pulmonary epithelium, hepatocytes, and skeletal muscle (16, (24) (25) (26) ( 16, 25) .
The known low rate of synoviocyte proliferation in vivo, combined with the normal histologic appearance ofsynovial tissues observed at later time points suggests that synoviocyte proliferation with subsequent loss of adenoviral DNA is not a significant mechanism for the loss of transgene expression. Alternative explanations for the progressive decline in lacZ expression observed in vivo include animal to animal variation, alterations in the transcriptional activity of the CMV promoter, direct toxicity of the transgene product, or the development of a neutralizing immune response. A relative persistence of lacZ expressing synoviocytes over tendon and bone compared to the synoviocytes overlying other subsynovial tissues was observed ( Fig. 1 B) , however the small number of animals examined in this initial study do not allow us to draw conclusions regarding the reasons for this observation. Additional experiments are currently underway to elucidate the reasons for the observed decline in transgene expression and to establish the temporal limits oflacZ activity in rabbit synovium in vivo using a variety Clinically, the experimental cohort of rabbits showed no evidence ofarthritis or synovitis within the infected hind knees throughout the experimental period, and there was no evidence of disease or severe inflammation on histopathologic examination of tissues < 8 wk after infection. Additionally, no adverse systemic side effects were observed in animals infected with either AdCMVlacZ or AdCSV.
The development of antibodies directed against adenoviral structural proteins and a foreign transgene by the host animals is not unexpected. Adenoviruses are ubiquitous amongst animal species and rabbit adenoviruses have been isolated and characterized (27, 28) . Cross-reactive antibodies to bovine adenoviruses in sera obtained from naive rabbits have previously been described (29) . Additionally, rabbits immunized with human adenoviruses can produce neutralizing antibodies crossreactive to endogenous rabbit adenoviruses (30) . The presence of antibodies against AdCMVlacZ proteins in rabbits before intraarticular infection, and the rapid development (within 1-2 wk) of a high titer against AdCMVlacZ proteins, suggests that members of this experimental cohort had been exposed previously to rabbit or human adenoviruses, despite maintenance in pathogen specific free housing. The time course ofthe (32) (33) (34) (35) (36) (37) . This molecule is endogenously expressed by human synoviocytes, and represents a reasonable candidate for therapeutic over-expression via direct in vivo infection ofsynoviocytes, with recombinant adenoviral vectors (32, 37) .
Ex vivo gene transfer using recombinant retroviruses to cells derived from type B rabbit synoviocytes has been reported, however the efficiency ofgene transfer is relatively low, and the technique is laborious (38) . In contrast, the use of recombinant adenoviral vectors for intraarticular infection is relatively simple and results in the efficient genetic transduction of both types of synovial lining cells, with persistence of transgene expression for 2 8 wk after infection. The results of these studies suggest that direct genetic modification of synoviocytes using adenoviral vectors in vivo may be a superior method for the intraarticular delivery of potentially therapeutic antiinflammatory proteins.
